2 completed. 2 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 2 | Completed 2 |
| Phase 2 | 1 | Completed 1 |
Follow Kidney Dysfunction: new trials by email Literature Review of Kidney Dysfunction trials Research Report on Kidney Dysfunction
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Safety, Tolerability, and Feasibility of Empagliflozin Therapy in Dialysis-dependent ESKD Empagliflozin, Placebo - End-stage Kidney Disease, Kidney Disease, Chronic | Phase 1 | Completed | University of Utah | 62 | 2023-03-21 | 2025-08-12 |
| The Effects of Decreasing the Lasix Dose on the Cardiorenal System Furosemide - Heart Failure, Kidney Dysfunction | Phase 1 / Phase 2 | Completed | Mayo Clinic | 41 | 2009-07-01 | 2015-07-20 |
Heart Failure (1) · Kidney Failure, Chronic (1) · Renal Insufficiency (1) · Renal Insufficiency, Chronic (1)
Cardiovascular Diseases (1) · Chronic Disease (1) · Disease Attributes (1) · Female Urogenital Diseases (1) · Female Urogenital Diseases and Pregnancy Complications (1) · Heart Diseases (1) · Kidney Diseases (1) · Male Urogenital Diseases (1) · Pathologic Processes (1) · Pathological Conditions, Signs and Symptoms (1) · Urogenital Diseases (1) · Urologic Diseases (1)
Furosemide (1) · empagliflozin (1)
Mayo Clinic (1) · University of Utah (1)
United States (2)
Horng H Chen, MD (1)
P01HL076611 (1), R01DK131265 (1), R01HL084155 (1), UL1TR000135 (1)